EQ
Equillium Inc

4,613
Loading...
Loading...
Equillium, Inc. is a clinical-stage biotechnology company that engages in the development of novel therapeutics to treat severe autoimmune and inflammatory disorders with high unmet medical need. Its product pipeline includes EQ001, which is a monoclonal antibody that selectively targets the novel immune checkpoint receptor CD6. The company was founded by Daniel Mark Bradbury, Bruce D. Steel, and Stephen Connelly in March 2017 and is headquartered in La Jolla, CA.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
35

Frequently Asked Questions

What is Market Cap of Equillium Inc?
What is the 52-week high for Equillium Inc?
What is the 52-week low for Equillium Inc?
What is Equillium Inc stock price today?
What was Equillium Inc stock price yesterday?
What is the PE ratio of Equillium Inc?
What is the Price-to-Book ratio of Equillium Inc?
What is the 50-day moving average of Equillium Inc?
How many employess does Equillium Inc has?

Latest EQ News

View

Advertisement. Remove ads.

Advertisement. Remove ads.